PRESS RELEASE published on 02/25/2025 at 06:30, 11 months 13 days ago Formycon receives regulatory approval in the UK for FYB203 (aflibercept), a biosimilar to Eylea®, under the brand name AHZANTIVE® Formycon receives regulatory approval in the UK for FYB203 (aflibercept), a biosimilar to Eylea®, under the brand name AHZANTIVE®. Approval for treating retinal diseases granted by UK's MHRA Regulatory Approval UK Biosimilar Formycon AHZANTIVE
PRESS RELEASE published on 02/25/2025 at 05:26, 11 months 13 days ago EQS-Adhoc: Dexus Finance Pty Limited: Appendix 3Y Change of Director's Interest Notice Dexus Finance Pty Limited announces Change of Director's Interest Notice for Rhoda Phillippo. Appendix 3Y form filed to ASX for public disclosure Real Estate Dexus Finance Pty Limited ASX Release Appendix 3Y Change Of Director's Interest Notice
PRESS RELEASE published on 02/25/2025 at 02:20, 11 months 13 days ago UniDoc - Announces Filing of Amended and Restated Interim Management Discussion and Analysis UniDoc Health Corp. issues amended and restated management's discussion and analysis for clarifying disclosure following continuous disclosure review by the British Columbia Securities Commission British Columbia Securities Commission Management's Discussion And Analysis UniDoc Health Corp. Amended Clarifying Disclosure
PRESS RELEASE published on 02/25/2025 at 00:05, 11 months 13 days ago BluSky Carbon Announces Closing of Convertible Debenture Financing and Unit Offering BluSky Carbon Inc. closes non-brokered private placement of convertible debentures and completes Unit Offering, raising funds for business development Private Placement Business Development Convertible Debentures BluSky Carbon Inc. Unit Offering
PRESS RELEASE published on 02/25/2025 at 00:00, 11 months 13 days ago Onco-Innovations' PKNP Technology Shown in Study to Demonstrate Low Toxicity and High Safety Profile Onco-Innovations Limited announces successful preclinical study results of its second-generation nanoparticle formulation of PNKP Compound, showing enhanced inhibitor delivery with minimal toxicity for potential cancer therapy Preclinical Study Cancer Therapy Onco-Innovations Limited Nanoparticle Formulation PNKP Compound
PRESS RELEASE published on 02/24/2025 at 22:15, 11 months 13 days ago Kingstone Announces Record Operating Profit and Growth for Fourth Quarter and Full Year 2024 Kingstone Companies, Inc. schedules conference call on March 14 for fourth quarter 2024 financial results. Company's preliminary financial performance highlights significant improvements in direct written premiums and operating income Financial Results Conference Call Kingstone Companies Inc. Preliminary Performance Direct Written Premiums
PRESS RELEASE published on 02/24/2025 at 21:27, 11 months 13 days ago Sanofi : Déclaration des transactions sur actions propres
PRESS RELEASE published on 02/24/2025 at 21:27, 11 months 13 days ago Sanofi: Disclosure of trading in own shares
PRESS RELEASE published on 02/24/2025 at 21:15, 11 months 13 days ago Shelly achieves a successful financial year 2024 with profitable growth well above the industry average Shelly Group SE achieves successful financial year 2024 with remarkable growth exceeding industry average, driven by revenue increase and international expansion Revenue Increase Financial Year 2024 Profitable Growth International Expansion Shelly Group SE
PRESS RELEASE published on 02/24/2025 at 21:14, 11 months 13 days ago Inside Information / Other news releases Pernod Ricard successfully completes €800 million bond issuance with a coupon of 3.25% for general corporate purposes, led by Bank of America and others Bond Issuance Bank Of America PERNOD RICARD €800 Million Coupon 3.25%
Published on 02/10/2026 at 15:30, 2 hours 51 minutes ago Predictiv AI Establishes Asia Regional Office to Support Expansion Across Asia, Africa, and the Middle East
Published on 02/10/2026 at 15:00, 3 hours 21 minutes ago Haven Safety AI Launches AI-Native Safety Intelligence Platform Co-Founded with The AES Corporation and AI Fund
Published on 02/10/2026 at 14:30, 3 hours 51 minutes ago Measles Orphan Drug Designation Application Filed for NV-387, Declares NanoViricides
Published on 02/10/2026 at 14:00, 4 hours 21 minutes ago Horizon Aircraft Partners with North Aircraft Industries to Manufacture the Wings for the Cavorite X7
Published on 02/10/2026 at 18:01, 20 minutes ago EuroTeleSites Fulfills 2025 Guidance: Revenue Grows and Rises to 280.2 mEUR; Deleveraging Down to 5.5x
Published on 02/10/2026 at 18:00, 20 minutes ago BOA CONCEPT: Une belle dynamique de commandes sur le marché français pour BOA Concept
Published on 02/10/2026 at 18:00, 21 minutes ago A1 Telekom Austria Group Q4 and full year 2025 results
Published on 02/10/2026 at 16:35, 1 hour 45 minutes ago Michter's To Release Celebration Sour Mash, The Rarest Whiskey in the Distiller's Lineup
Published on 02/10/2026 at 18:00, 21 minutes ago CIS remporte plusieurs contrats stratégiques en Afrique, en Amérique du Sud et en Asie
Published on 02/10/2026 at 18:00, 21 minutes ago CIS wins several strategic contracts in Africa, South America and Asia
Published on 02/09/2026 at 18:00, 1 day ago LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 31 janvier 2026